Dynasil Corporation of America (DYSL):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:Dynasil Corporation of America (DYSL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME183091D
◆発行会社(調査会社):GlobalData
◆発行日:2017年1月23日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:米国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dynasil Corporation of America (Dynasil) develops and manufactures optics and photonics products. The company also provides optical detection and analysis technology and components. Its products include beamsplitters, diffraction gratings, infrared optics, mirrors and reflectors, optical filters, optical interference filters, optical systems and subsystems, replicated optics and others. Dynasil offers its products to lighting and projection, laser, space, sensors and imaging, defense and industrial applications. The company has a presence in the US and the UK. Dynasil is headquartered in Newton, Massachusetts, the US.

Dynasil Corporation of America (DYSL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Dynasil Corporation of America, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dynasil Corporation of America, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dynasil Corporation of America, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dynasil Corporation of America, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Dynasil Corporation of America, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Dynasil Corporation of America, Medical Equipment, Deal Details 10
Asset Purchase 10
Dynasil Biomedical Acquires Rights To Six Biomedical Technologies 10
Venture Financing 10
Xcede Technologies Raises USD0.96 Million in Venture Financing 10
Xcede Raises Additional USD1.4 Million in Venture Financing 11
Partnerships 12
Cook Biotech Enters into Licensing Agreement with Xcede 12
Mayo Clinic Enters Into Co-Development Agreement With Dynasil 12
Debt Offering 13
Dynasil Completes Private Placement Of Subordinated Notes For US$3 Million 13
Asset Transactions 14
Dilon Diagnostics Completes Acquisition Of Navigator Gamma Medical Probe Product Line Assets From Dynasil For US$3.5 Million 14
Acquisition 15
Evaporated Metal Films Acquires DichroTec Thin Films 15
Dynasil Corporation of America – Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Dynasil Corporation of America, Medical Equipment, Key Facts, 2015 1
Dynasil Corporation of America, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Dynasil Corporation of America, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dynasil Corporation of America, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dynasil Corporation of America, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dynasil Corporation of America, Deals By Market, 2011 to YTD 2017 8
Dynasil Corporation of America, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Dynasil Biomedical Acquires Rights To Six Biomedical Technologies 10
Xcede Technologies Raises USD0.96 Million in Venture Financing 10
Xcede Raises Additional USD1.4 Million in Venture Financing 11
Cook Biotech Enters into Licensing Agreement with Xcede 12
Mayo Clinic Enters Into Co-Development Agreement With Dynasil 12
Dynasil Completes Private Placement Of Subordinated Notes For US$3 Million 13
Dilon Diagnostics Completes Acquisition Of Navigator Gamma Medical Probe Product Line Assets From Dynasil For US$3.5 Million 14
Evaporated Metal Films Acquires DichroTec Thin Films 15
Dynasil Corporation of America, Key Competitors 17
Dynasil Corporation of America, Key Employees 18
Dynasil Corporation of America, Subsidiaries 19

List of Figures
Dynasil Corporation of America, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Dynasil Corporation of America, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Dynasil Corporation of America, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Dynasil Corporation of America, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Dynasil Corporation of America, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dynasil Corporation of America, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Dynasil Corporation of America, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dynasil Corporation of America, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

★海外企業調査レポート[Dynasil Corporation of America (DYSL):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ciena Corporation:企業の戦略・SWOT・財務分析
    Ciena Corporation - Strategy, SWOT and Corporate Finance Report Summary Ciena Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kina Petroleum Limited (KPL):企業のM&A・提携動向(石油・ガス分野)
    Summary Kina Petroleum Limited (KPL) is an oil and gas company, which carries out exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to proven are …
  • Mr. Price Group Ltd.:企業の戦略・SWOT・財務情報
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務情報
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Fate Therapeutics, Inc. (FATE)(製薬・医療分野):企業M&A動向
    Summary Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of adult stem cell pharmacologic modulators for the patients with rare life threatening disorders. The company has developed two platforms, namely, HSC Modul …
  • ASKA Pharmaceutical Co Ltd (4514):企業財務及び戦略的SWOT分析
    Summary ASKA Pharmaceutical Co Ltd (ASKA) is a pharmaceutical company that manufactures and sells pharmaceuticals, quasi-drugs, foods, medical devices and veterinary medicines. The company imports and export pharmaceutical and medical device. Its activities comprise production, drug information, and …
  • The Scoular Company:企業の戦略的SWOT分析
    The Scoular Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • SymBio Pharmaceuticals Ltd (4582):企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …
  • Bank of Bahrain and Kuwait:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bank of Bahrain and Kuwait Merg …
  • Sanovas Inc:医療機器:M&Aディール及び事業提携情報
    Summary SanovasInc (Sanovas) is a developer of diagnostic solutions that develops access, imaging, measurement, therapeutic technologies and solutions for physician. The company provides imaging technologies, interventional lung, interventional ENT, and interventional uro and gyn products, among oth …
  • Opexa Therapeutics, Inc. (OPXA):企業のM&A・提携動向(医療機器分野)
    Summary Opexa Therapeutics, Inc. (Opexa) formerly PharmaFrontiers and Opexa Pharmaceuticals, is a biotechnology company that develops autologous cellular therapies for the treatment of sclerosis, rheumatoid arthritis, neuromyelitis optica, diabetes and heart failure. Its product Tcelna, is a persona …
  • Chemring North America:企業の戦略・SWOT・財務分析
    SummaryChemring North America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Pure Cycle Corporation (PCYO):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Pure Cycle Corporation" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fo …
  • MSIG Insurance (Malaysia) Bhd.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "MSIG Insurance (Malaysia) Bhd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric str …
  • LodgeNet Interactive Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' LodgeNet Interactive Corporatio …
  • McKinsey & Company, Inc.:戦略・SWOT・企業財務分析
    McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • HanAll Biopharma Co Ltd (009420):製薬・医療:M&Aディール及び事業提携情報
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a pharmaceutical company that offers drug delivery, biotherapeutics, and small molecule discovery programs. The company develops drugs in therapeutic areas of ophthalmology, immunology, cardiovascular disease, dermat …
  • Parenteral Drug India Ltd (PDPL):企業財務及び戦略的SWOT分析
    Summary Parenteral Drug India Ltd (PDIL) is a pharmaceutical company that discovers, researches, develops and manufactures pharmaceutical products. The company offers products such as solid and liquid orals, IV fluids, oncology products and critical care products. It also offers I.V. Paracetamol, pr …
  • amcure GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Amcure GmbH (Amcure) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of cancer. The company develops peptide-based compounds for the treatment of metastatic forms of cancer. Its lead candidate, AMC303 is used for the treatment of metastatic epithelia …
  • CafePress, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CafePress, Inc. Mergers and Acq …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆